Characterization of a specific receptor for somatomedin C (SM-C) on cultured human lymphocytes: evidence that SM-C modulates homologous receptor concentration
- PMID: 6253277
- DOI: 10.1210/endo-107-6-1841
Characterization of a specific receptor for somatomedin C (SM-C) on cultured human lymphocytes: evidence that SM-C modulates homologous receptor concentration
Abstract
A membrane receptor for somatomedin C (SM-C) on cultured IM-9 cells has recently been reported. The current studies were undertaken to further characterize this intact cellular receptor in terms of both kinetics and specificity and to investigate the ability of SM-C to induce homologous receptor loss. The binding of [125I]iodo-SM-C was rapid, achieving a steady state within 90 min and was greater than 95% reversible. Specific binding at 15C averaged 25-30% for 20 X 10(6) cells/ml. Competition for binding was observed at SM concentrations as low as 2 mU/ml, with half-maximal displacement of [125I]iodo-SM-C at SM concentrations of 33 mU/ml (3.33 X 10(-9) M). Insulin-like growth factor I (IGF-I) and a purified SM-C preparation were approximately equipotent in their ability to displace [125I]iodo-SM-C from the IM-9 receptor. The relative potencies of other growth-related peptides, in comparison with SM-C/IGF-I, were IGF-II (1:10), multiplication stimulating activity (1:10), insulin (1:100), and hGH (nonreactive). Preexposure of IM-9 cells to SM-C at 37 C resulted in a time- and concentration-dependent reduction in [125I]iodo-SM-C. A 10-15% decrease in binding was observed after preincubation with SM in concentrations of 7 mU/ml. Preincubation with 100 mU/ml SM resulted in 50% reduction in binding, but no further decreases were observed after preincubation with higher concentrations of SM (up to 1 U/ml). Scatchard analysis indicated that the reduction in binding was due to a loss of available specific receptors on the cell membrane. These data indicate that the IM-9 cell possesses a specific SM receptor and that SM-C and IGF-I compete equally for occupancy. Furthermore, the data provide a direct demonstration in cell culture that SM-C, like insulin and growth hormone, can modulate homologous receptor concentrations and potentially alter target-cell sensitivity.
Similar articles
-
Characterization and regulation of a specific cell membrane receptor for somatomedin-C/insulin-like growth factor I in cultured rat granulosa cells.Endocrinology. 1988 Jan;122(1):194-201. doi: 10.1210/endo-122-1-194. Endocrinology. 1988. PMID: 2961555
-
Interaction of insulin-like growth factor I with porcine thyroid cells cultured in monolayer.Endocrinology. 1987 Aug;121(2):749-56. doi: 10.1210/endo-121-2-749. Endocrinology. 1987. PMID: 3036481
-
Insulin-induced loss of insulin-like growth factor-I receptors on IM-9 lymphocytes.Diabetes. 1982 May;31(5 Pt 1):375-81. doi: 10.2337/diab.31.5.375. Diabetes. 1982. PMID: 6295857
-
Chemistry, structure, and function of insulin-like growth factors and their receptors: a review.Can J Biochem Cell Biol. 1984 Nov;62(11):1237-45. doi: 10.1139/o84-158. Can J Biochem Cell Biol. 1984. PMID: 6098361 Review.
-
Somatomedins and steroids.Horm Res. 1986;24(2-3):185-8. doi: 10.1159/000180558. Horm Res. 1986. PMID: 3530941 Review.
Cited by
-
Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro.J Clin Invest. 1988 Sep;82(3):950-7. doi: 10.1172/JCI113703. J Clin Invest. 1988. PMID: 3262126 Free PMC article.
-
Insulin-like growth factor binding to the atypical insulin receptors of a human lymphoid-derived cell line (IM-9).Biochem J. 1990 Mar 15;266(3):737-42. doi: 10.1042/bj2660737. Biochem J. 1990. PMID: 2327961 Free PMC article.
-
Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation.EMBO J. 2006 Jan 11;25(1):58-69. doi: 10.1038/sj.emboj.7600917. Epub 2005 Dec 15. EMBO J. 2006. PMID: 16362038 Free PMC article.
-
Regulation of insulin-like growth factor (IGF) I receptor expression during muscle cell differentiation. Potential autocrine role of IGF-II.J Clin Invest. 1991 Apr;87(4):1212-9. doi: 10.1172/JCI115121. J Clin Invest. 1991. PMID: 1849146 Free PMC article.
-
Acromegaly, inflammation and cardiovascular disease: a review.Rev Endocr Metab Disord. 2020 Dec;21(4):547-568. doi: 10.1007/s11154-020-09560-x. Rev Endocr Metab Disord. 2020. PMID: 32458292 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials